Heparin induced thrombocytopenia and thrombosis in a tertiary care hospital

Thrombosis Research

Volumn 124, Issue 2, 2009, Pages 189-192

  Ban Hoefen, Makiko ^a   Francis, Charles ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANTIBODY TITER; ANTICOAGULANT THERAPY; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPARIN INDUCED THROMBOCYTOPENIA; HEPARINIZATION; HUMAN; INTRACARDIAC THROMBOSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPTICAL DENSITY; PORTAL VEIN THROMBOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STROKE; TERTIARY HEALTH CARE; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; THROMBOSIS;

EID: 67249094457     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.01.006     Document Type: Article

References (31)

1. Zwicker J.I., Uhl L., Huang W.Y., Shaz B.H., and Bauer K.A. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. JTH 2 12 (2004) 2133-2137
2. Warkentin T.E., Roberts R.S., Hirsh J., and Kelton J.G. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients. Arch Intern Med 163 20 (2003) 2518-2524
3. Greinacher A., Farner B., Kroll H., Kohlmann T., Warkentin T.E., and Eichler P. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost 94 1 (2005) 132-135
4. Warkentin T.E., Levine M.N., Hirsh J., Horsewood P., Roberts R.S., Gent M., et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 332 20 (1995) 1330-1335
5. Demasi R., Bode A.P., Knupp C., Bogey W., and Powell S. Heparin-induced thrombocytopenia. Am Surgeon 60 1 (1994) 26-29
6. Schmitt B.P., and Adelman B. Heparin-associated thrombocytopenia: A critical review and pooled analysis. Am J Med Sci 305 4 (1993) 208-215
7. Girolami B., and Girolami A. Heparin-induced thrombocytopenia: A review. Semin Thromb Hemost 32 8 (2006) 803-809
8. Prandoni P., Siragusa S., Girolami B., Fabris F., BELZONI Investigators, and G. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: A prospective cohort study. Blood 106 9 (2005) 3049-3054
9. Martel N., Lee J., and Wells P.S. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: A meta-analysis. Blood 106 8 (2005) 2710-2715
10. Smythe M.A., Koerber J.M., and Mattson J.C. The incidence of recognized heparin-induced thrombocytopenia in a large, tertiary care teaching hospital. Chest 131 6 (2007) 1644-1649
11. LaMonte M.P., Brown P.M., and Hursting M.J. Stroke in patients with heparin-induced thrombocytopenia and the effect of argatroban therapy. Crit Care Med 32 4 (2004) 976-980
12. Warkentin T.E., and Kelton J.G. A 14-year study of heparin-induced thrombocytopenia. Am J Med 101 5 (1996) 502-507
13. Lo G.K., Sigouin C.S., and Warkentin T.E. What is the potential for overdiagnosis of heparin-induced thrombocytopenia?. Am J Hematol 82 12 (2007) 1037-1043
14. Fabris F., Luzzatto G., Soini B., Ramon R., Scandellari R., Randi M.L., et al. Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia. J Intern Med 252 2 (2002) 149-154
15. Davoren A., and Aster R.H. Heparin-induced thrombocytopenia and thrombosis. Am J Hematol 81 1 (2006) 36-44
16. Gruel Y., Pouplard C., Nguyen P., Borg J.Y., Derlon A., Juhan-Vague I., et al. Biological and clinical features of low-molecular-weight heparin-induced thrombocytopenia. Br J Haematol 121 5 (2003) 786-792
17. Warkentin T.E., Sheppard J.A., Sigouin C.S., Kohlmann T., Eichler P., and Greinacher A. Gender imbalance and risk factor interactions in heparin-induced thrombocytopenia. Blood 108 9 (2006) 2937-2941
18. Warkentin T.E., Sheppard J.A., Horsewood P., Simpson P.J., Moore J.C., and Kelton J.G. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood 96 5 (2000) 1703-1708
19. Girolami B., Prandoni P., Stefani P.M., Tanduo C., Sabbion P., Eichler P., et al. The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: A prospective cohort study. Blood 101 8 (2003) 2955-2959
20. Wallis D.E., Workman D.L., Lewis B.E., Steen L., Pifarre R., and Moran J.F. Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia. Am J Med 106 6 (1999) 629-635
21. Warkentin T.E., Sheppard J.A., Moore J.C., Moore K.M., Sigouin C.S., and Kelton J.G. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: How much class do we need?. J LabClin Med 146 6 (2005) 341-346
22. Pouplard C., Gueret P., Fouassier M., Ternisien C., Trossaert M., Regina S., et al. Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia. J Thromb Haemost 5 (2007) 1373-1379
23. Warkentin T.E. Heparin-induced thrombocytopenia: pathogenesis and management. Br J Haematol 121 (2003) 535-555
24. Kelton J.G., Sheridan D., Brain H., et al. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 103 4 (1984) 606-612
25. Arepally G.M., and Ortel T.L. Clinical practice. heparin-induced thrombocytopenia. N Engl J Med 355 8 (2006) 809-817
26. Pouplard C., Amiral J., Borg J.Y., Laporte-Simitsidis S., Delahousse B., and Gruel Y. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia. Am J Clin Pathol 111 5 (1999) 700-706
27. Schenk S., El-Banayosy A., Morshuis M., Arusoglu L., Eichler P., Lubenow N., et al. IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost : JTH 5 2 (2007) 235-241
28. Martinuzzo M.E., Forastiero R.R., Adamczuk Y., Pombo G., and Carreras L.O. Antiplatelet factor 4-heparin antibodies in patients with antiphospholipid antibodies. Thromb Res 95 6 (1999) 271-279
29. Amiral J., Marfaing-Koka A., Wolf M., Alessi M.C., Tardy B., Boyer-Neumann C., et al. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia. Blood 88 2 (1996) 410-416
30. Keeling D., Davidson S., Watson H., and Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology. The management of heparin-induced thrombocytopenia. Br J Haematol 133 3 (2006) 259-269
31. Suh J.S., Malik M.I., Aster R.H., et al. Characterization of the humoral immune response in heparin-indcued thrombocytopenia. Am J Hematol 54 3 (1997) 196-201